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The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information 
about opioid use and Iowa’s efforts to address the national opioid epidemic. Please feel free to 
submit topics to Julie Jones at julie.jones@idph.iowa.gov.  
 
In this issue:  
 
• Department Efforts 
• Legislative Interest 




AmeriCorps RFP Released 
 
The Iowa Department of Public Health (IDPH), Division of Behavioral Health, Bureau of 
Substance Abuse proposes to support 30 AmeriCorps members (15 full time and 15 half time).  
Members will provide education to Iowa communities on substance abuse, particularly opioid 
and prescription drug abuse; build capacity of organizations who need to broaden 
understanding of opioid and prescription drug abuse; and form coalitions and partners to 
address the growing crisis.  
 
At the end of the first program year, AmeriCorps members will increase community education, 
knowledge, and awareness on prescription drug and opioid abuse and enhance program 
capacity and sustainability of substance abuse prevention programs, mentoring programs, and 
recovery community organizations. In addition, AmeriCorps members will recruit 300 volunteers 
who will be engaged in 1100 hours of service. 
 




House File 2377  
 
As previously mentioned, the Iowa House of Representatives passed House File 2377.  The bill 
includes a variety of opioid-related efforts, including: 
 
• Prescriber registration and use of the Prescription Monitoring Program (PMP) prior to 
issuing an opioid prescription 
• Transmission of prescription information for controlled substances by a pharmacy to the 
PMP within one business day of the dispensing 
• Adoption of a Good Samaritan law to provide certain protections for good-faith actions to 
seek medical assistance for an individual experiencing an overdose 
• Provider education on the CDC Guideline for Prescribing Opioids for Chronic Pain  
 
The bill passed the Senate Human Resources Committee and has moved on to the Senate 







President Trump Announces Initiative to Stop Opioid Abuse 
 
On March 19, 2018, President Trump announced his new opioid initiative to stop opioid abuse 
and reduce drug supply and demand.  The President’s Initiative is divided into three areas:  
 
REDUCE DEMAND AND OVER-PRESCRIPTION: President Trump’s Opioid Initiative will 
educate Americans about the dangers of opioid and other drug use and seek to curb 
over-prescription. 
• Launch a nationwide evidence-based campaign to raise public awareness about the 
dangers of prescription and illicit opioid use, as well as other drug use.   
• Support research and development efforts for innovative technologies and additional 
therapies designed to prevent addiction and decrease the use of opioids in pain 
management. 
o This will include supporting research and development for a vaccine to prevent 
opioid addiction and non-addictive pain management options. 
• Reduce the over-prescription of opioids which has the potential to lead Americans down 
a path to addiction or facilitate diversion to illicit use. 
• Implement a Safer Prescribing Plan to achieve the following objectives: 
o Cut nationwide opioid prescription fills by one-third within three years.  
o Ensure that 75 percent of opioid prescriptions reimbursed by Federal healthcare 
programs are issued using best practices within three years, and 95 
percent within five years.  
o Ensure that at least half of all Federally-employed healthcare providers adopt 
best practices for opioid prescribing within two years, with all of them doing 
so within five years.  
o Leverage Federal funding opportunities related to opioids to ensure that States 
transition to a nationally interoperable Prescription Drug Monitoring Program 
network.  
  
CUT OFF THE SUPPLY OF ILLICIT DRUGS: President Trump’s Opioid Initiative will crack 
down on international and domestic illicit drug supply chains devastating American 
communities:    
• Keep dangerous drugs out of the United States 
o Secure land borders, ports of entry, and water ways against illegal smuggling.  
o Require advance electronic data for 90 percent of all international mail shipments 
(with goods) and consignment shipments within three years, in order for the 
Department of Homeland Security to flag high-risk shipments. 
o Identify and inspect high-risk shipments leveraging advanced screening 
technologies and by using drug-detecting canines.  
o Test and identify suspicious substances in high-risk international packages to 
quickly detect and remove known and emerging illicit drugs before they can 
cause harm. 
o Engage with China and expand cooperation with Mexico to reduce supplies of 
heroin, other illicit opioids, and precursor chemicals.  
• Advance the Department of Justice (DOJ) Prescription Interdiction and Litigation (PIL) 
Task Force to fight the prescription opioid crisis. The PIL Task Force will: 
o Expand the DOJ Opioid Fraud and Abuse Detection Unit’s efforts to prosecute 
corrupt or criminally negligent doctors, pharmacies, and distributors. 
o Aggressively deploy appropriate criminal and civil actions to hold opioid 
manufacturers accountable for any unlawful practices. 
 
• Shut down illicit opioid sales conducted online and seize any related assets.  
o Scale up internet enforcement efforts under DOJ’s new Joint Criminal Opioid 
Darknet Enforcement (J-CODE) team.    
• Strengthen criminal penalties for dealing and trafficking in fentanyl and other opioids:  
o DOJ will seek the death penalty against drug traffickers, where appropriate under 
current law.  
o The President also calls on Congress to pass legislation that reduces the 
threshold amount of drugs needed to invoke mandatory minimum sentences for 
drug traffickers who knowingly distribute certain illicit opioids that are lethal in 
trace amounts.  
 
HELP THOSE STRUGGLING WITH ADDICTION: President Trump’s Opioid Initiative will 
help those struggling with addiction through evidence-based treatment and recovery 
support services:   
• Work to ensure first responders are supplied with naloxone, a lifesaving medication used 
to reverse overdoses.   
• Leverage Federal funding opportunities to State and local jurisdictions to incentivize and 
improve nationwide overdose tracking systems that will help resources to be rapidly 
deployed to hard-hit areas. 
• Expand access to evidence-based addiction treatment in every State, particularly 
Medication-Assisted Treatment for opioid addiction. 
• Seek legislative changes to the law prohibiting Medicaid from reimbursing residential 
treatment at certain facilities with more than 16 beds.  o In the meantime, continue 
approving State Medicaid demonstration projects that waive these barriers to inpatient 
treatment. 
• Provide on-demand, evidence-based addiction treatment to service members, veterans 
and their families eligible for healthcare through the Departments of Defense or Veterans 
Affairs. 
• Leverage opportunities in the criminal justice system to identify and treat offenders 
struggling with addiction. 
o Screen every Federal inmate for opioid addiction at intake.  
o For those who screen positive and are approved for placement in residential 
reentry centers, facilitate naltrexone treatment and access to treatment prior to 
and while at residential reentry centers and facilitate connection to community 
treatment services as needed.  
o Scale up support for State, Tribal, and local drug courts in order to provide 
offenders struggling with addiction access to evidence-based treatment as an 
alternative to or in conjunction with incarceration, or as a condition of supervised 
release. 
 
 
 
 
 
 
 
 
 
